Rock8 Science’s Post

View organization page for Rock8 Science, graphic

1,454 followers

Should Australia look towards creating a radiopharmaceutical specific reimbursement pathway? As it currently stands there are both MSAC and PBAC avenues but the process is fragmented and poorly understood. The latest MSAC PSD gives clear evidence of this. With so much investment in nuclear medicine globally, is Australia at risk of falling behind? https://lnkd.in/gEg4AJg9

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics